Psychiatry & Neurology Doctors in Spring Grove, PA Accepting Medicare

2 Psychiatry & Neurology doctors found. Showing 1 - 2

Divya Jalota, D.O Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 2030 Thistle Hill Dr Ste 202, Spring Grove, PA 17362 Phone: 717-843-7348    Fax: 717-771-5393

Beth L Jolly, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 2030 Thistle Hill Dr Ste 202, Spring Grove, PA 17362 Phone: 717-843-7348    Fax: 717-771-5393

News Archive

SBRT shortens radiation treatment time for gynecologic cancers

About 71,500 women in the United States are diagnosed with a gynecologic cancer every year, according to the Centers for Disease Control. Researchers from University Hospitals Case Medical Center have developed a more effective way to treat gynecologic cancers, shortening radiation treatment time from five weeks to three days. The method will be published in the Journal of Visualized Experiments (JoVE) on April 17.

RyMed's InVision-Plus IV Connector decreases catheter-related bloodstream infections by 92.6%

Georgia Health Sciences University, Augusta, GA exhibited a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed RyMed Technologies' zero displacement InVision-Plus® IV Connector significantly decreased the incidence of catheter-related bloodstream infections (CR-BSIs) by 92.6% on average when compared to a simple split septum with negative displacement IV connector (Becton-Dickinson Q-Syte®) and a reversed split-septum device with negative displacement IV connector (ICU Medical Clave®).

Researchers discover 'broad spectrum' cancer suppressor gene

Portuguese researchers have discovered a "broad spectrum" cancer suppressor gene - called LRP1B - which acts by removing proteins crucial for cancer development from the tumour environment. The fact that LRP1B does not act on the tumour itself (in this study thyroid tumours) but, instead, on molecules which are known to be important to many different cancers is what makes it so interesting.

Alnylam and Tekmira to collaborate on RNAi therapeutics

Alnylam Pharmaceuticals, Inc. and Tekmira Pharmaceuticals Corporation announced today that they will jointly participate in a new research collaboration focused on the discovery of novel cationic lipids and lipid nanoparticles for the systemic delivery of RNAi therapeutics.

Enzo Biochem and NEI join to conduct a human clinical trial of Enzo's chronic autoimmune uveitis therapeutic

Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquel™, Enzo's oral, proprietary therapeutic for chronic autoimmune uveitis.

Read more Medical News

› Verified 5 days ago